MISTTherapy, which was approved by the FDA in October 2004, was developed by a Minnesota company named Celleration.
气雾疗法在2004年获得FDA的批准，是由一家名为Celleration的明尼苏达公司开发的。
2
Objective To evaluate the clinical therapeutic effect and security of vapor-mist diacutis therapy of traditional Chinese medicine in the treatment of fibromyalgia syndrome (FMS).